Experimental and clinical studies have demonstrated that the levels and activity of p53 are highly increased in PD cellular and animal models as well as in the brains of PD patients, and these changes are closely associated with the dysfunction of mitochondria and the cell death of dopaminergic neurons [8]. This evidence concerns the gene TP53 and Parkinson disease.